Revasum Inc
ASX:RVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revasum Inc
ASX:RVS
|
US |
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
TH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RVS's stock price target?
Not Available
RVS doesn't have any price targets made by Wall Street professionals.
What is Revasum Inc's Revenue forecast?
Projected CAGR
12%
For the last 4 years the
compound annual growth rate for
Revasum Inc's revenue is
-14%.
The projected
CAGR
for the next 3 years is
12%.